C918 人眼脉络黑色素瘤细胞

C918细胞系是一种人眼脉络黑色素瘤细胞系，来源于人类黑色素瘤（60岁女性的葡萄膜黑色素瘤），是患者的转移部位的细胞系。C918细胞系广泛应用于研究与黑色素瘤相关模型，包括它们的生长模式、转移潜力和对治疗药物的反应。C918细胞移植到免疫缺陷小鼠体内具有成瘤性，其在体外表现出高增殖率和抵抗细胞凋亡的能力，被广泛应用于研究与黑色素瘤进展相关的细胞信号通路。据报道STR检测发现，三株人侵袭性脉络膜黑色素瘤细胞C918、M619和Mum-2B为同一遗传背景，怀疑存在交叉污染。

动物种别：人

组织来源：眼脉络膜，葡萄膜黑色素瘤 

形态：上皮细胞样，贴壁生长

培养基配方：1640完全培养基（货号：MD0201）

气相：空气，95%；二氧化碳，5%。 温度：37℃。

冻存条件：90%FBS（SD0200)+10%DMSO

完全冻存液：免程序降温细胞冻存液（低血清）(SD0001)

声明：产品仅科研使用。

PubMed=8683940
Karla Jean Daniels, Herbert Culver Boldt, James A. Martin, Lynn M. Gardner, Margaret Meyer, Robert Folberg;
Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression.
Lab. Invest. 75:55-66(1996)

PubMed=10952317; DOI=10.1038/35020115
Michael Bittner, Paul S. Meltzer, Yi-Dong Chen, Yuan Jiang, Elisabeth A. Seftor, Mary J.C. Hendrix, Michael D. Radmacher, Richard M. Simon, Zohar Yakhini, Amir Ben-Dor, Nick Sampas, Edward Russell Dougherty, Ena Wang, Francesco M. Marincola, Gerald C. Gooden, John Lueders, Arthur Glatfelter, Pamela M. Pollock, John D. Carpten, Elizabeth M. Gillanders, Darryl Leja, Kathleen Dietrich, Christian Beaudry, Michael E. Berens, David Samuel Alberts, Vernon K. Sondak, Nicholas K. Hayward, Jeffrey M. Trent;
Molecular classification of cutaneous malignant melanoma by gene expression profiling.
Nature 406:536-540(2000)

PubMed=18689700; DOI=10.1167/iovs.08-2324; PMCID=PMC2576485
Robert Folberg, ShriHari S. Kadkol, Shahar Frenkel, Klara Valyi-Nagy, Martine Johanna Jager, Jacob Pe'er, Andrew J. Maniotis;
Authenticating cell lines in ophthalmic research laboratories.
Invest. Ophthalmol. Vis. Sci. 49:4697-4701(2008)

PubMed=22383533; DOI=10.1158/1535-7163.MCT-11-0676
Ken Dutton-Regester, Darryl Irwin, Priscilla Hunt, Lauren G. Aoude, Varsha Tembe, Gulietta M. Pupo, Cathy Lanagan, Candace D. Carter, Linda O'Connor, Michael O'Rourke, Richard Anthony Scolyer, Graham J. Mann, Christopher W. Schmidt, Adrian Herington, Nicholas K. Hayward;
A high-throughput panel for identifying clinically relevant mutation profiles in melanoma.
Mol. Cancer Ther. 11:888-897(2012)